• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Meta-analysis of the clinical efficacy of Liqi Huoxue drop pill in the treatment of angina pectoris in coronary artery disease

    2022-02-04 10:32:10HANYiHANYuboZOUGuoliangSUIYanboDONGXinyuLIULi
    Journal of Hainan Medical College 2022年21期
    關鍵詞:滴丸理氣胸痹

    HAN Yi, HAN Yu-bo, ZOU Guo-liang, SUI Yan-bo, DONG Xin-yu, LIU Li?

    1. Heilongjiang University of Traditional Chinese Medicine, Harbin 150040, China

    2. The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin 150040, China

    Keywords:

    ABSTRACT

    1. Introduction

    Coronary artery disease is short for coronary heart disease, also known as ischemic heart disease, and is clinically divided into five types, namely asymptomatic, angina pectoris, myocardial infarction,ischemic cardiomyopathy and sudden death, among which the coronary angina pectoris type is more common. The pathological mechanism of coronary angina is atherosclerosis or the formation of plaque in the inner wall of blood vessels, which leads to luminal narrowing or blood rheology changes, resulting in impaired coronary circulation, which in turn affects the blood supply to cardiomyocytes. The main clinical symptoms of coronary angina are chest discomfort or posterior sternal paroxysmal pressure during episodes that affect patients' quality of life, and in severe cases,myocardial infarction or even life-threatening [1]. Coronary angina has been one of the major causes of death in China. The index of suffering from coronary angina in China has increased significantly compared to previous years, mainly due to the dramatic deterioration of the prevalence of coronary angina-causing risk factors such as hypertensive disease, hyperlipidemia, and diabetes[2]. At present, the clinic mainly adopts a comprehensive program of anticoagulation,cardiac strengthening, vasodilatation, and lipid regulation[3], and conventional Western medicine treatment can be effective, but also has certain toxic side effects, while Chinese medicine has little side effects and significant therapeutic effects, which provides a new treatment idea for the clinic.

    Chinese medicine is often used as a supplement and alternative to Western medicine in the treatment of coronary angina, and the combination of Chinese and Western medicine can improve the efficacy of coronary angina treatment, reduce the incidence of coronary angina, and avoid the adverse reactions and side effects of Western medicine treatment. It is a new Chinese medicine developed by China for the treatment of angina pectoris in coronary heart disease, and it is a proprietary Chinese medicine preparation based on Chinese medicine theory and modern preparation technology. It consists of four Chinese herbal medicines, namely, Daguomujiangzi,Bingqi (natural ice chips), Chuanxiong and Allium, which have the effects of broadening the chest and dispersing knots, regulating Qi and activating blood flow [4]. There have been a certain number of RCT trials on the combination of Li qi huo xue dropping pills with western medicine on angina pectoris in coronary heart disease, but evidence from evidence-based medicine is still lacking. The aim of this study was to evaluate the efficacy of combining Li qi huo xue dropping pills with western drugs in the treatment of angina pectoris in coronary heart disease, with the aim of providing evidencebased medical evidence for the clinical application of Li qi huo xue dropping pills in the treatment of angina pectoris in coronary heart disease. Because there are few clinical randomized controlled trials on the combination of Li qi huo xue dropping pills with Western medicine for the treatment of angina pectoris in coronary heart disease, a more convincing subgroup analysis of outcome indicators could not be performed, so only Meta-analysis of relevant indicators was performed.

    2. Materials and Methods

    2.1 Literature search strategy

    Search by computer in Chinese databases (CNKI, VIP, WanFang Data and CBM) with"理氣活血滴丸","心絞痛","冠心病","冠心病心絞痛","胸痹", etc.In English databases (PubMed,Embase, Web of Science, Cochrane Library) with "Lifting qi and activating blood drop pills", "Li qi huo xue dropping pills", and "Coronary heart disease", "CHD", "angina pectoris", "random control trial", etc.The search was conducted using a combination of subject terms and free words. For PubMed, for example, see Box 1 for the specific search strategy.Box 1 PubMed search strategy

    2.2 Inclusion and exclusion criteria

    2.2.1 Study type

    A randomized controlled trial (RCT) of Li qi huo xue drop pill for the treatment of angina pectoris in coronary artery disease, with no restrictions on the publisher's rank or region and restrictions on language to Chinese or English only.

    2.2.2 Research subjectsThe subjects included in the study must be patients diagnosed with coronary angina, and the diagnostic criteria were referred to the relevant diagnostic criteria for coronary angina in Nomenclature and diagnostic criteria of ischemic heart disease [5].

    2.2.3 Interventions

    Control group: conventional Western medical treatment with unlimited types, doses and courses of Western medicine.

    Intervention group: Combined with the Li qi huo xue drop pill on the basis of the control group.

    2.2.4 Ending indicators

    ① clinical efficacy, ②efficacy of angina symptoms, ③number of angina attacks, ④serum inflammatory index interleukin-6 (IL-6),⑤serum interleukin-18 (IL-18), ⑥high-sensitivity C-reactive protein(hs-CRP), ⑦endothelial function index nitric oxide (NO)

    2.2.5 Exclusion criteria

    ①literature in which the type of study was animal experiments or pharmacological studies;②literature in which severe cardiac, hepatic,or renal insufficiency and drug allergy were combined;③literature in which the control and treatment groups included acupuncture,surgery, or other treatment modalities;④literature with obvious data errors;⑤literature with missing data;⑥literature in languages other than Chinese or English;⑦iterature with duplicate publications;⑧l(xiāng)iterature that has not been published.

    2.3 Risk of bias evaluation of included studies

    The included clinical randomized controlled studies were assessed for "risk of bias" using the "risk of bias assessment" tool recommended in the Cochrane 5.1.0 manual. The assessment was based on random sequence generation, allocation concealment,blinding of patients and participants, blinding of outcome assessors,completeness of outcome data, selective reporting, and other biases.Two investigators gave low risk, unclear, or high risk assessments for the included as-randomized controlled trials, and the two cross-checked their respective results after completion. If the two investigators disagreed with the results, they were referred to a third person for risk of bias assessment.

    2.4 Statistical treatment

    Meta-analysis of the included literature data was performed using RevMan 5.4 software provided by the Cochrane Collaboration Network. Measured variables (continuous variables) Weighted mean difference (WMD) was used as a statistic when the same intervention was measured by the same method or unit, otherwise, standard mean difference (SMD) was used as a statistic. The relative riskiness (RR)of the count variable was used as an effect size analysis statistic.Heterogeneity in the included studies was determined using the χ2test (detectionlevela= 0.1). When P≥0.1 and I2≤50%, the heterogeneity of the study data was low and a fixed-effects model should be used; when P < 0.1 and I2> 50%, it indicated that there was significant heterogeneity in the study data and a heterogeneous random-effects model should be used and the source of heterogeneity should be further analyzed. If significant clinical heterogeneity was present, subgroup analysis was performed. If clinical heterogeneity was evident but subgroup analysis could not be performed, Metaanalysis could not be performed and only descriptive analysis could be used. When the number of primary data indicators in the included studies was greater than 10, funnel plots should be used to assess publication bias.

    3. Results

    3.1 Literature screening process and results

    Based on the above search criteria, a total of 87 relevant papers were obtained. The full text was carefully read and screened according to the inclusion and exclusion criteria, and only 9 papers met the inclusion criteria [6-14]. The observation group was treated with the combination of Western medicine using the Li qi huo xue drop pill and included 491 patients. The control group was treated with conventional Western medicine only and included a total of 491 patients. The literature screening process is shown in Figure 1.

    3.2 Quality evaluation results of the included studies

    Regarding the method of random assignment, one study was high risk [8]and randomized by time of visit, hospitalization number,and clinical treatment intention method. seven studies mentioned randomization only and did not specify the random assignment scheme [6,9-14]. one study was low risk [7] and reported specific random grouping methods, including random number table methodassignment. The random assignment scheme was concealed, and aspects of blinding and other sources of bias were unclear, resulting in low risk for both data completeness and selective reporting. The results of the risk of bias assessment for the included studies are shown in Figure 2.

    Tab1 Basic information of literature included

    Fig1 Flowchart of literature screening

    Fig2 Risk of bias of literature included

    3.3 Meta-analysis results

    3.3.1 Clinical efficacyFive clinical randomized controlled trials reporting clinical efficacy were included [6-10], as shown. Each study was homogeneous(P=0.90; I2=0%). Statistical analyses were performed using homogeneity fixed-effects models. The RR and 95% CI for clinical efficacy were RR = 1.20 and 95% CI = [(1.12, 1.29) P<0.000 01];the results showed that the intervention group had better clinical efficacy than the control group, and the difference was statistically significant. (Figure 3)

    Fig3 Forest plot of clinical efficacy of angina in coronary heart disease between intervention and control group

    3.3.2 Efficacy of angina pectoris symptomsThree clinical randomized controlled trials reporting the efficacy of angina symptoms were included [11-13], as shown. Each study was homogeneous (P=0.85; I2=0%). Statistical analyses were performed using a homogeneous fixed effects model. The RR and 95% CI for angina symptom efficacy were RR = 1.17 and 95% CI = [(1.07, 1.29)P = 0.001]; the results showed that the intervention group had better angina symptom efficacy than the control group, and the difference was statistically significant. (Figure 4)

    3.3.3 Number of angina attacks

    The number of angina episodes reported by the 3 clinical randomized controlled trials [8,13,14] was included, as shown. Each study was heterogeneous (P<0.000 01; I2=97%). Statistical analysis was performed using a heterogeneous random-effects model. for the number of angina attacks [SMD= -2.26, 95% CI (-4.10,-0.42),P=0.002]; the results showed that the number of angina attacks was lower in the intervention group than in the control group, and the difference was statistically significant. (Figure 5)

    3.3.4 Serum inflammatory indicator interleukin-6 ( IL-6)

    Four clinical randomized controlled trials reporting interleukin-6 were included [6,9,11], as shown. Each study was heterogeneous(P=0.11; I2=55%). Statistical analysis was performed using a heterogeneous random effects model. The [MD= -4.65, 95% CI(-6.91,-2.39), P<0.000 1] for interleukin-6; the results showed that interleukin-6 was lower in the intervention group than in the control group, and the difference was statistically significant. (Figure 6)

    Fig4 Forest plot of clinical efficacy of angina in coronary heart disease between intervention and control group

    Fig5 Forest plot of angina attacks in coroary heart disease of both groups

    Fig6 Forest plot of IL-6 comparison of angina in coronary heart disease of both groups

    3.3.5 Serum inflammatory indicator interleukin-18 ( IL-18)

    Interleukin-18 reported in 3 clinical randomized controlled trials were included [9,10,12], as shown. Each study was homogeneous(P=0.23; I2=32%). Statistical analysis was performed using a homogeneity fixed-effects model. Interleukin-18 of [MD=-2.53, 95%CI (-2.84,-2.22), P<0.000 01]; the results showed that interleukin-18 was lower in the intervention group than in the control group, and the difference was statistically significant. (Figure 7)

    Fig7 Forest plot of IL-8 comparison of angina in coronary heart disease of both groups

    3.3.6 High-sensitivity C-reactive protein (HS-CRP)

    High-sensitivity C-reactive protein reported in four clinical randomized controlled trials [6,9,11,14] was included, as shown. Each study was heterogeneous (P=0.31; I2=55%). Statistical analysis was performed using a heterogeneous random effects model. The[MD=-0.08, 95% CI (1.81,-0.75), P<0.000 01] for high-sensitivity C-reactive protein; the results showed that the intervention group had lower high-sensitivity C-reactive protein than the control group, and the difference was statistically significant. (Figure 8)

    3.3.7 Endothelial function indicator nitric oxide (NO)

    Three clinical randomized controlled trials reporting on endothelial function indicators of nitric oxide were included[8,11,14], as shown.Each study was heterogeneous (P<0.000 01; I2=96%). Statistical analysis was performed using a heterogeneous random effects model. for the endothelial function index nitric oxide [MD= 8.03,95% CI (0.93,15.14), P=0.03]; the results showed that the endothelial function index nitric oxide was higher in the intervention group than in the control group, and the difference was statistically significant.(Figure 9)

    Fig8 Forest plot of Hs-CRP comparison of angina in coronary heart disease of both groups

    Fig9 Forest plot of NO comparison of angina in coronary heart disease of both groups

    3.3.8 Adverse drug reactionsIn one study, there was one case of headache and dizziness, three cases of gastrointestinal discomfort, and one case of rash in the control group; in the intervention group, there were two cases of headache and dizziness and five cases of gastrointestinal discomfort;in one study, there were two cases of vomiting, three cases of abdominal pain, and two cases of rash in the control group; and in the intervention group, there were two cases of epigastric discomfort and one case of rash. (Table 2)

    Tab2 Adverse reaction events of the drug used

    3.3.9 Sensitivity analysis

    All the outcome indicators included in the study were ranked one by one to find the source of heterogeneity. When sensitivity analysis was performed on the indicator IL-6, it was found that excluding the study of Shi Ming et al [11], heterogeneity was reduced (P<0.000 01, I2=0%), and the results showed that IL-6 was significantly lower in the intervention group than in the control group [MD= -5.82,95% CI (-6.92,-4.71), P<0.000 01]. When sensitivity analysis was performed on the index IL-18, a reduced heterogeneity (P<0.000 01,I2=0%) was found excluding the study of Weng Jiao et al [9], which showed that IL-18 was lower in the intervention group than in the control group [MD= -2.66, 95% CI (-3.01,-2.31), P<0.000 01]. When sensitivity analysis was performed on the index HS-CRP, a reduction in heterogeneity (P<0.000 01, I2=0%) was found excluding the study of Li Yan et al [6], which showed that HS-CRP in the intervention group was lower than in the control group [MD=-1.53, 95% CI(-1.93,-1.14) , P<0.000 01]. When sensitivity analysis was performed on this indicator of NO, it was found that excluding the study of Shi Ming et al [11], heterogeneity was reduced (P<0.000 01, I2= 0%),and the results showed that NO was higher in the intervention group than in the control group [MD=4.23, 95% CI (2.49,5.97), P<0.000 01]. The final results were not significantly different from those before the exclusion of heterogeneous sources. When analyzing the heterogeneity of other indicators, the heterogeneity did not vary significantly and is not listed. The results of the heterogeneity analysis indicate that the results of this study are relatively stable and have reference value.

    3.3.9 Publication bias

    Because of the small number of studies included for individual outcome indicators, this study was not tested for publication bias.

    4. Discussion

    In recent years, the incidence of coronary angina has increased significantly in China. The symptoms of clinical patients during attacks are no longer limited to pain in the anterior region of the heart, but have even seriously affected their psychological status and quality of life. At present, the drugs commonly used clinically for the treatment of coronary angina are mainly western drugs such as nitroglycerin, beta-blockers and calcium channel blockers. However,the long-term use of these western drugs may cause side effects such as gastrointestinal bleeding, slow heart rate or low blood pressure,and the long-term efficacy is not satisfactory. Therefore, there is a great need to find a treatment option for angina pectoris with few side effects and significant efficacy.

    Angina pectoris in coronary artery disease belongs to the category of "chest paralysis" in Chinese medicine. According to Chinese medicine, "chest paralysis" is mainly due to deficiency of qi and blood and blood stasis blocking the heart arteries. The pathogenesis of pain in the anterior region of the heart is due to deficiency of qi,blood, yin and yang in the body, and phlegm, cold, qi stagnation and blood stasis blocking the heart arteries and channels, resulting in"pain when it does not pass". The effect of Li qi huo xue dropping pill is to benefit Qi, warm Yang, activate blood circulation and remove blood stasis, which can effectively reduce the clinical symptoms of patients. The main ingredient of Li qi huo xue dropping pills is Dagongmujiangzi, which was found to have a protective effect on myocardial injury in a rat model of atrial fibrillation and acute myocardial ischemia[15,16]. Ice chips have the effect of opening the body and waking the mind, clearing heat and relieving pain, and based on modern network pharmacological investigation, it was found that there are three targets in ice chips that have important efficacy in the treatment of coronary heart disease, effectively targeting the symptoms and eliminating the disease[17]. Allium sativum has the ability to move qi and channel stagnation, pass yang and disperse nodules, which can eliminate blood stasis and ensure smooth blood circulation. The other main ingredient, Chuanxiong,has the function of activating blood circulation, dispelling wind and relieving pain. Modern research has proved that Chuanxiong has the function of promoting blood circulation, anti-inflammatory, anticoagulation and vasodilation, it can significantly reduce the viscosity of whole blood and plasma, inhibit platelet aggregation, increase coronary blood flow, improve cardiac microcirculation, and reduce plaque formation [18], and Chuanxiong has a protective effect on cardiovascular endothelial cells, which is the one of the best drugs to choose in the treatment of chest paralysis[19]. Combined together,the four drugs promote qi-blood circulation, harmonize qi and blood,and exorcise stasis, ventilate qi, and relieve pain.

    In this paper, through Meta-analysis of nine included studies,the results showed that the intervention group was significantly better than the control group in improving clinical efficacy and the efficacy of angina pectoris symptoms, indicating that Li qi huo xue dropping pill can effectively improve the clinical symptoms of patients with coronary angina pectoris. The increase of highsensitivity C-reactive protein indicates the high level of vascular inflammation, which leads to the instability of arterial plaque,and high-sensitivity C-reactive protein is an effective independent predictor of cardiovascular disease [20]. The changes in endothelial function and coronary angina are closely related to each other [21],and damage to endothelial structure and function is an important cause of atherosclerotic plaque formation and the earliest sign of vascular lesions[22],and have a predictive value for long-term cardiovascular events, which were lower in the intervention group than in the control group, indicating that Li qi huo xue dropping pill can effectively inhibit the inflammatory response of the body to have a protective effect on the myocardium; the results of this study showed that Li qi huo xue dropping pill can improve the clinical efficacy of angina pectoris in coronary heart disease to some extent,and can reduce IL-6, IL-18.The results of the present study showed that Li qi huo xue dropping pills could improve the clinical efficacy of angina pectoris in coronary heart disease to a certain extent, and could reduce IL-6, IL-18, HS-CRP levels and the number of angina attacks, and improve NO levels and the efficacy of angina symptoms,indicating that Li qi huo xue dropping pills has a better therapeutic effect on angina pectoris in coronary heart disease, and can also improve patients' quality of life and delay disease progression. In terms of safety, two studies reported adverse reactions. 8 cases of gastrointestinal discomfort, 1 case of dizziness and 3 cases of skin rash were observed in the control group. In the intervention group,there were 8 cases of gastrointestinal discomfort, 2 cases of dizziness and headache, 7 cases of gastrointestinal discomfort, and 1 case of rash. There were no serious adverse reactions in the intervention group, and the incidence of adverse reactions in the intervention group was lower than that in the control group, suggesting the relatively high safety of the treatment with Li qi huo xue dropping pills.

    In conclusion, the combination of Li qi huo xue dropping pill with conventional western medicine treatment for patients with coronary angina can effectively improve the clinical outcome, the efficacy of angina symptoms, the number of angina attacks, the NO index of endothelial function, and reduce serum inflammatory indexes IL-6,IL-18, and HS-CRP.

    However, the consistency among studies was not high due to the low quality of the literature of the original studies included and the limited number of samples included, the different control measures, and the large variety of drugs included in the conventional treatment in Western medicine. This meta-analysis also has some limitations:①None of the nine studies included in this paper mentioned blinding and allocation concealment, one study used the randomized numerical table method, and the rest did not describe the randomization method, which made the quality of the studies poor;all studies did not describe patient loss or withdrawal, which did not correspond to the clinical reality and the data may be untrue; different drug doses, length of intervention The differences in drug doses,duration of intervention, and measurement of indicators may lead to increased heterogeneity of the studies. Therefore, more multicenter,large sample, double-blind and other high-quality randomized controlled clinical trials are needed for further confirmation to better guide clinical drug use.②The number of studies included in this study was small, and the included studies were published in China,and the populations were all Chinese populations or even small parts of China, and it is unclear whether the findings of this study are also applicable to other regions or other ethnic groups.③Also, due to language ability limitations, our search was limited to Chinese and English literature, and we may have overlooked studies or reports in other languages. Therefore the above study findings still need to be supported by more high-quality clinical randomized controlled trials and high-quality literature to provide a more reliable therapeutic basis for modern clinical practice.

    Author Contribution Description

    (First author)Han Yi:research design, implementation of the study,data collection and statistical analysis, and article writing.

    (Second author)Han Yubo:work supervision, article content review.

    (Third author) Zou Guoliang:work supervision, technical support,etc.

    (Fourth author) Sui Yanbo:work supervision, technical support, etc.

    (Fifth author) Dong Xinyu:collection and statistical data, etc.

    (Corresponding author) Liu Li:research design, work direction,article review, etc.

    Conflict of Interest Statement

    The author declares that the content and opinions expressed in the paper are neutral and objective, and that there is no conflict of interest.

    猜你喜歡
    滴丸理氣胸痹
    理氣舒筋法在人工全膝關節(jié)置換術后加速康復中的應用研究
    張艷治療胸痹臨床經驗
    活血化瘀法論治胸痹
    穿心蓮內酯滴丸
    胸痹氣虛證療效評價量表探討
    對朱子理氣關系論的重新考察
    船山學刊(2017年4期)2017-08-10 18:27:19
    HPLC法測定蒙藥新Ⅰ號滴丸中沒食子酸的含量
    連參滴丸制備工藝的優(yōu)選
    厚樸花滴丸質量標準的研究
    辨證施護胸痹60例
    老司机亚洲免费影院| 午夜福利视频精品| 久久久久久免费高清国产稀缺| 日本91视频免费播放| 国产成人精品福利久久| av在线观看视频网站免费| 可以免费在线观看a视频的电影网站 | 亚洲情色 制服丝袜| 黄色视频在线播放观看不卡| 男人添女人高潮全过程视频| 国产精品久久久久久人妻精品电影 | 一级a爱视频在线免费观看| 女人高潮潮喷娇喘18禁视频| av.在线天堂| 精品国产一区二区久久| 丝袜美足系列| 老司机靠b影院| 午夜福利,免费看| 麻豆av在线久日| 啦啦啦在线观看免费高清www| 人妻人人澡人人爽人人| 人人妻,人人澡人人爽秒播 | 电影成人av| 中文精品一卡2卡3卡4更新| 一区二区三区乱码不卡18| 狠狠精品人妻久久久久久综合| 91精品三级在线观看| 久久99精品国语久久久| 最近中文字幕高清免费大全6| 黄网站色视频无遮挡免费观看| 少妇被粗大的猛进出69影院| 日韩av在线免费看完整版不卡| 一本色道久久久久久精品综合| 成人国产av品久久久| 亚洲精品中文字幕在线视频| 看免费成人av毛片| 人人妻人人澡人人看| 啦啦啦在线免费观看视频4| 超碰97精品在线观看| 亚洲精华国产精华液的使用体验| 亚洲精品日韩在线中文字幕| 天堂8中文在线网| 韩国高清视频一区二区三区| 亚洲国产日韩一区二区| 免费不卡黄色视频| av电影中文网址| 亚洲少妇的诱惑av| 久久精品国产亚洲av高清一级| 一本—道久久a久久精品蜜桃钙片| 99九九在线精品视频| 久久人人97超碰香蕉20202| 黄色视频不卡| 最黄视频免费看| 天美传媒精品一区二区| 亚洲av成人不卡在线观看播放网 | 欧美激情 高清一区二区三区| 视频在线观看一区二区三区| 天堂8中文在线网| 亚洲精品在线美女| 十八禁网站网址无遮挡| e午夜精品久久久久久久| 99久久综合免费| 亚洲av在线观看美女高潮| 国产免费现黄频在线看| 中国三级夫妇交换| 亚洲欧美日韩另类电影网站| 捣出白浆h1v1| 久久久精品国产亚洲av高清涩受| 91精品国产国语对白视频| 久久久久久人人人人人| 香蕉丝袜av| 各种免费的搞黄视频| 欧美人与性动交α欧美软件| 精品一品国产午夜福利视频| 99热网站在线观看| 欧美日韩视频高清一区二区三区二| 一级毛片我不卡| 亚洲av综合色区一区| av在线老鸭窝| av视频免费观看在线观看| 成年人免费黄色播放视频| 一级毛片黄色毛片免费观看视频| 美女主播在线视频| 校园人妻丝袜中文字幕| 一二三四在线观看免费中文在| 伊人久久大香线蕉亚洲五| 日韩欧美一区视频在线观看| 国产免费现黄频在线看| 午夜福利网站1000一区二区三区| 亚洲天堂av无毛| 成人三级做爰电影| 啦啦啦在线免费观看视频4| 最近的中文字幕免费完整| 久久毛片免费看一区二区三区| 国产精品国产三级专区第一集| 青春草亚洲视频在线观看| 另类精品久久| 国产男女超爽视频在线观看| 美女扒开内裤让男人捅视频| 婷婷色av中文字幕| 欧美激情极品国产一区二区三区| av又黄又爽大尺度在线免费看| 丝袜脚勾引网站| 欧美变态另类bdsm刘玥| 91aial.com中文字幕在线观看| 日本av手机在线免费观看| 中文字幕亚洲精品专区| 国产av精品麻豆| 亚洲成国产人片在线观看| 亚洲精品日本国产第一区| 精品人妻在线不人妻| 免费高清在线观看视频在线观看| 亚洲情色 制服丝袜| 久久久久久久大尺度免费视频| videosex国产| 在线观看三级黄色| 男人爽女人下面视频在线观看| 久久精品aⅴ一区二区三区四区| 亚洲av国产av综合av卡| 久久国产亚洲av麻豆专区| 亚洲少妇的诱惑av| a级毛片在线看网站| 青青草视频在线视频观看| 狠狠精品人妻久久久久久综合| 色网站视频免费| 自拍欧美九色日韩亚洲蝌蚪91| 国产精品免费视频内射| 黄色一级大片看看| 色综合欧美亚洲国产小说| 少妇 在线观看| 亚洲精品一二三| 日本午夜av视频| 大片免费播放器 马上看| 国产精品麻豆人妻色哟哟久久| 精品福利永久在线观看| 久久热在线av| 国产亚洲精品第一综合不卡| 日韩av在线免费看完整版不卡| 黄色怎么调成土黄色| 日韩制服丝袜自拍偷拍| 电影成人av| 午夜免费鲁丝| 精品一区二区三卡| 又大又爽又粗| 国产成人a∨麻豆精品| 久久久国产欧美日韩av| 麻豆av在线久日| av国产精品久久久久影院| 久久精品国产a三级三级三级| 肉色欧美久久久久久久蜜桃| 9色porny在线观看| 国产一区有黄有色的免费视频| 国产精品 国内视频| 91老司机精品| 日本欧美视频一区| av免费观看日本| 最近手机中文字幕大全| 亚洲,欧美,日韩| 免费不卡黄色视频| 久久精品久久久久久久性| 看十八女毛片水多多多| 国产片内射在线| 老司机靠b影院| 精品国产乱码久久久久久男人| av网站在线播放免费| 亚洲欧美激情在线| 肉色欧美久久久久久久蜜桃| 成人影院久久| tube8黄色片| 婷婷色麻豆天堂久久| 免费观看性生交大片5| av在线app专区| 国产精品 国内视频| av在线播放精品| 精品亚洲成国产av| 91国产中文字幕| 99九九在线精品视频| 久久精品aⅴ一区二区三区四区| 亚洲熟女精品中文字幕| 久久久久网色| 亚洲成av片中文字幕在线观看| 亚洲伊人久久精品综合| 热re99久久精品国产66热6| 午夜福利免费观看在线| 久久午夜综合久久蜜桃| 一个人免费看片子| 69精品国产乱码久久久| 国产精品一区二区精品视频观看| 国产成人精品在线电影| 亚洲国产精品一区三区| 午夜影院在线不卡| 亚洲熟女精品中文字幕| 国产精品免费视频内射| 中文字幕人妻丝袜制服| 亚洲 欧美一区二区三区| 国产又爽黄色视频| 人人妻人人澡人人看| 丝袜脚勾引网站| 国产欧美亚洲国产| 国产男人的电影天堂91| 丝瓜视频免费看黄片| 国产精品久久久久久人妻精品电影 | 美女午夜性视频免费| 在线观看免费日韩欧美大片| 成年人午夜在线观看视频| 国产精品二区激情视频| 亚洲欧洲日产国产| 亚洲图色成人| 只有这里有精品99| 亚洲四区av| 深夜精品福利| 国产精品 欧美亚洲| 自线自在国产av| 伊人亚洲综合成人网| 国精品久久久久久国模美| 美女中出高潮动态图| 波多野结衣一区麻豆| 免费日韩欧美在线观看| 亚洲精品久久午夜乱码| 久久久久久人人人人人| 九草在线视频观看| 只有这里有精品99| 欧美日韩视频高清一区二区三区二| 天堂俺去俺来也www色官网| 久久毛片免费看一区二区三区| 免费人妻精品一区二区三区视频| 亚洲欧洲精品一区二区精品久久久 | 在现免费观看毛片| 欧美在线黄色| 国产女主播在线喷水免费视频网站| 精品午夜福利在线看| 亚洲精品日本国产第一区| 久久婷婷青草| av网站免费在线观看视频| 亚洲精品国产色婷婷电影| 久久精品久久久久久久性| 国产成人精品福利久久| 女人精品久久久久毛片| 国产精品久久久久成人av| 日韩视频在线欧美| 电影成人av| 天堂8中文在线网| 伊人久久大香线蕉亚洲五| 精品国产一区二区三区久久久樱花| 极品人妻少妇av视频| 免费日韩欧美在线观看| 欧美在线黄色| 人成视频在线观看免费观看| 丰满乱子伦码专区| 亚洲精品国产区一区二| 国产黄色免费在线视频| 黄色视频在线播放观看不卡| 男女免费视频国产| 嫩草影院入口| 亚洲第一青青草原| 男女国产视频网站| 亚洲精品久久成人aⅴ小说| 国产麻豆69| 一区二区三区激情视频| 国产成人精品久久二区二区91 | 另类亚洲欧美激情| 国产亚洲欧美精品永久| 久久久国产欧美日韩av| 99久久精品国产亚洲精品| 老汉色∧v一级毛片| 亚洲精品aⅴ在线观看| 男男h啪啪无遮挡| 亚洲精华国产精华液的使用体验| 男女边吃奶边做爰视频| 男人添女人高潮全过程视频| 中文字幕色久视频| 高清在线视频一区二区三区| 国产精品成人在线| 一级黄片播放器| 在线看a的网站| 国产成人a∨麻豆精品| 久久av网站| 亚洲欧洲日产国产| 久久精品熟女亚洲av麻豆精品| 亚洲欧美成人综合另类久久久| 国产日韩欧美视频二区| 亚洲激情五月婷婷啪啪| 国产精品99久久99久久久不卡 | 青春草国产在线视频| 国产成人精品久久二区二区91 | 国产欧美亚洲国产| 久久久久久久精品精品| 免费在线观看完整版高清| 日韩av免费高清视频| 久久久久久人妻| 中文欧美无线码| 欧美精品亚洲一区二区| 午夜福利网站1000一区二区三区| 老司机亚洲免费影院| 成人亚洲欧美一区二区av| xxxhd国产人妻xxx| 18禁国产床啪视频网站| 国产亚洲最大av| 精品国产一区二区三区四区第35| 一本—道久久a久久精品蜜桃钙片| 久久久久久久大尺度免费视频| 只有这里有精品99| 亚洲欧美日韩另类电影网站| 视频在线观看一区二区三区| 免费黄色在线免费观看| 精品福利永久在线观看| 久久久久精品性色| 国产精品久久久久久人妻精品电影 | 久久鲁丝午夜福利片| 亚洲欧洲精品一区二区精品久久久 | 最近最新中文字幕大全免费视频 | 久久久国产欧美日韩av| 最近最新中文字幕免费大全7| 狠狠精品人妻久久久久久综合| 亚洲美女黄色视频免费看| 国产黄色视频一区二区在线观看| 老鸭窝网址在线观看| 超碰成人久久| 国产免费福利视频在线观看| 色婷婷久久久亚洲欧美| 成人毛片60女人毛片免费| 一级毛片我不卡| 久久精品aⅴ一区二区三区四区| 免费观看a级毛片全部| 一区二区三区激情视频| 你懂的网址亚洲精品在线观看| 多毛熟女@视频| 男人添女人高潮全过程视频| 国产精品人妻久久久影院| 精品亚洲乱码少妇综合久久| 日日撸夜夜添| 国产野战对白在线观看| 中文字幕色久视频| 亚洲欧美色中文字幕在线| 免费不卡黄色视频| 日本91视频免费播放| 日本vs欧美在线观看视频| 久久人人97超碰香蕉20202| 99精品久久久久人妻精品| 婷婷成人精品国产| 别揉我奶头~嗯~啊~动态视频 | 少妇 在线观看| 精品福利永久在线观看| 一级a爱视频在线免费观看| 中文天堂在线官网| 国产精品99久久99久久久不卡 | 欧美日韩亚洲高清精品| 久久久久精品久久久久真实原创| 久久人人97超碰香蕉20202| 少妇被粗大猛烈的视频| 免费黄色在线免费观看| 欧美最新免费一区二区三区| 男女边摸边吃奶| 永久免费av网站大全| 国产精品 欧美亚洲| 蜜桃国产av成人99| 在线看a的网站| 2021少妇久久久久久久久久久| 在线天堂最新版资源| 亚洲欧美一区二区三区久久| 精品国产乱码久久久久久男人| 美国免费a级毛片| 国产高清不卡午夜福利| 一本大道久久a久久精品| 精品国产乱码久久久久久男人| 日韩免费高清中文字幕av| 你懂的网址亚洲精品在线观看| 亚洲欧美清纯卡通| 国产女主播在线喷水免费视频网站| 中文乱码字字幕精品一区二区三区| 久久99一区二区三区| 一本久久精品| 亚洲久久久国产精品| 哪个播放器可以免费观看大片| bbb黄色大片| 超碰成人久久| videosex国产| 国精品久久久久久国模美| 极品人妻少妇av视频| 成年人午夜在线观看视频| 欧美日本中文国产一区发布| 男女国产视频网站| 日韩电影二区| 一本—道久久a久久精品蜜桃钙片| 悠悠久久av| 交换朋友夫妻互换小说| 女人爽到高潮嗷嗷叫在线视频| 亚洲成av片中文字幕在线观看| 免费av中文字幕在线| 国产免费又黄又爽又色| 视频区图区小说| 晚上一个人看的免费电影| 亚洲精品久久久久久婷婷小说| 男人爽女人下面视频在线观看| 久久国产精品大桥未久av| 黄色毛片三级朝国网站| 国产探花极品一区二区| 成人18禁高潮啪啪吃奶动态图| 久久精品熟女亚洲av麻豆精品| 色吧在线观看| 男人舔女人的私密视频| 亚洲熟女精品中文字幕| 韩国av在线不卡| 久久天躁狠狠躁夜夜2o2o | 又粗又硬又长又爽又黄的视频| 韩国精品一区二区三区| 亚洲人成电影观看| av不卡在线播放| 波野结衣二区三区在线| 日日摸夜夜添夜夜爱| 国产av一区二区精品久久| 爱豆传媒免费全集在线观看| 亚洲美女搞黄在线观看| 汤姆久久久久久久影院中文字幕| 欧美人与性动交α欧美软件| 男女床上黄色一级片免费看| 成年女人毛片免费观看观看9 | xxx大片免费视频| 午夜精品国产一区二区电影| 亚洲国产欧美一区二区综合| 亚洲综合精品二区| 在线天堂中文资源库| 免费久久久久久久精品成人欧美视频| 亚洲av成人不卡在线观看播放网 | 精品一品国产午夜福利视频| 国产成人91sexporn| 美女视频免费永久观看网站| 人成视频在线观看免费观看| 丝袜美足系列| 高清视频免费观看一区二区| 亚洲精品国产色婷婷电影| 一本一本久久a久久精品综合妖精| 一区二区三区四区激情视频| 久久国产精品大桥未久av| 超碰成人久久| 亚洲人成电影观看| 熟妇人妻不卡中文字幕| 成人国产av品久久久| 女人精品久久久久毛片| 久久婷婷青草| 日韩成人av中文字幕在线观看| 看十八女毛片水多多多| 在现免费观看毛片| 欧美日韩成人在线一区二区| 免费黄网站久久成人精品| 视频区图区小说| 国产日韩欧美亚洲二区| 看十八女毛片水多多多| 男男h啪啪无遮挡| 久久人妻熟女aⅴ| 国产1区2区3区精品| 国产av码专区亚洲av| 国产精品久久久久久精品电影小说| 国产精品国产三级专区第一集| 女人被躁到高潮嗷嗷叫费观| 亚洲成国产人片在线观看| 成人午夜精彩视频在线观看| 啦啦啦中文免费视频观看日本| 19禁男女啪啪无遮挡网站| 99九九在线精品视频| 欧美在线一区亚洲| 亚洲精品国产区一区二| 女人精品久久久久毛片| 国产精品国产av在线观看| 看免费av毛片| 女人久久www免费人成看片| 我要看黄色一级片免费的| 永久免费av网站大全| 建设人人有责人人尽责人人享有的| 亚洲一卡2卡3卡4卡5卡精品中文| 精品亚洲成国产av| 亚洲欧洲精品一区二区精品久久久 | 久久性视频一级片| 黑人巨大精品欧美一区二区蜜桃| 一级片'在线观看视频| 国产伦理片在线播放av一区| 99九九在线精品视频| 亚洲av欧美aⅴ国产| 精品国产超薄肉色丝袜足j| 久久这里只有精品19| 日韩 欧美 亚洲 中文字幕| 丰满迷人的少妇在线观看| 亚洲中文av在线| 亚洲四区av| 亚洲精品,欧美精品| 亚洲伊人色综图| 国产亚洲欧美精品永久| 精品人妻熟女毛片av久久网站| 一级毛片我不卡| a级毛片在线看网站| 久久久久久人人人人人| 成人三级做爰电影| 不卡视频在线观看欧美| 亚洲四区av| 91国产中文字幕| 亚洲少妇的诱惑av| 久久ye,这里只有精品| 精品酒店卫生间| 欧美国产精品va在线观看不卡| 国产精品国产三级专区第一集| 韩国精品一区二区三区| 欧美国产精品一级二级三级| 日韩熟女老妇一区二区性免费视频| 不卡av一区二区三区| 日韩大码丰满熟妇| 亚洲少妇的诱惑av| av天堂久久9| 色94色欧美一区二区| 欧美日韩精品网址| 中文字幕人妻熟女乱码| 国产xxxxx性猛交| 日韩成人av中文字幕在线观看| 你懂的网址亚洲精品在线观看| 韩国av在线不卡| 性少妇av在线| 亚洲成人国产一区在线观看 | 在线观看人妻少妇| 欧美中文综合在线视频| 伦理电影大哥的女人| 曰老女人黄片| 又大又黄又爽视频免费| 国产精品香港三级国产av潘金莲 | www.自偷自拍.com| 欧美中文综合在线视频| 亚洲av日韩精品久久久久久密 | 老司机靠b影院| av又黄又爽大尺度在线免费看| 国产精品二区激情视频| 日本欧美国产在线视频| 免费观看a级毛片全部| 欧美在线黄色| 国产av国产精品国产| 亚洲精品aⅴ在线观看| 国产欧美日韩一区二区三区在线| 亚洲综合色网址| 在线天堂中文资源库| 一边摸一边抽搐一进一出视频| av免费观看日本| 亚洲国产看品久久| 久久国产亚洲av麻豆专区| 伊人亚洲综合成人网| 免费黄网站久久成人精品| 免费av中文字幕在线| 夫妻性生交免费视频一级片| 亚洲精品成人av观看孕妇| 国产麻豆69| 1024香蕉在线观看| 咕卡用的链子| 欧美亚洲 丝袜 人妻 在线| 精品亚洲成国产av| 色视频在线一区二区三区| 亚洲七黄色美女视频| 999精品在线视频| 成人三级做爰电影| 女人久久www免费人成看片| 国产黄色视频一区二区在线观看| 极品人妻少妇av视频| 久久亚洲国产成人精品v| 婷婷色综合www| 欧美日韩视频精品一区| 久久久久久久精品精品| 久久久久久久久久久免费av| 9191精品国产免费久久| 国产有黄有色有爽视频| 老司机亚洲免费影院| 日韩一本色道免费dvd| 久久久精品区二区三区| 69精品国产乱码久久久| 亚洲精品一区蜜桃| 久久久久国产一级毛片高清牌| 考比视频在线观看| 欧美日韩视频高清一区二区三区二| 国产精品.久久久| 日韩欧美精品免费久久| 男女免费视频国产| 亚洲精品第二区| 免费观看a级毛片全部| 亚洲av在线观看美女高潮| 亚洲综合色网址| 国产一卡二卡三卡精品 | 日韩制服丝袜自拍偷拍| 中国三级夫妇交换| 人妻 亚洲 视频| 综合色丁香网| 老司机影院毛片| 久久久久精品性色| 日本av免费视频播放| 嫩草影视91久久| 一级片'在线观看视频| 午夜福利,免费看| 国产免费一区二区三区四区乱码| 久久99一区二区三区| 久久久久久免费高清国产稀缺| 日韩制服骚丝袜av| 成年动漫av网址| 亚洲情色 制服丝袜| 国产精品一区二区在线观看99| 久久久久网色| 国产精品成人在线| 亚洲av在线观看美女高潮| 大片电影免费在线观看免费| a级片在线免费高清观看视频| 毛片一级片免费看久久久久| 天天操日日干夜夜撸| 国产精品久久久久久久久免| 18禁裸乳无遮挡动漫免费视频| 亚洲精华国产精华液的使用体验| 午夜福利视频精品| 永久免费av网站大全| 午夜精品国产一区二区电影| 在线观看国产h片| 永久免费av网站大全| 国产日韩欧美亚洲二区| 国产av国产精品国产| 亚洲精品久久久久久婷婷小说|